Better, faster, stronger! Taking on the eGERD market
Cinclus Pharma is a Swedish late-stage biopharmaceutical company developing a proprietary drug candidate, linaprazan glurate (LG), a next generation and potential best-in-class Potassium Competitive Acid Blocker (PCAB), which is a fast-acting regulator of intragastric pH by a different MoA than PPI
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.